ABSTRACT
Common variable immunodeficiency (CVID) is the most frequent symptomatic primary immunodeficiency (PID) in general population. PID are genetic diseases that share a dysfunction in the immune system entailing a greater risk of both chronic and recurrent infections. These patients can also develop chronic gastrointestinal infections caused by norovirus with persistent viral dissemination, which can be detected months after primoinfection. Additionally, a proportion of CVID patients show a typical severe enteropathy presenting with recurrent diarrhoea, intestinal malabsorption, inflammatory lesions, and villous atrophy. Some studies have related this enteropathy with chronic intestinal infection caused by norovirus.
Subject(s)
Caliciviridae Infections , Common Variable Immunodeficiency , Gastrointestinal Diseases , Graft vs Host Disease , Humans , Common Variable Immunodeficiency/complications , Common Variable Immunodeficiency/pathology , Reinfection , Caliciviridae Infections/complications , Caliciviridae Infections/pathology , Diarrhea , Graft vs Host Disease/complicationsSubject(s)
Chagas Disease , Musculoskeletal Diseases , Vasculitis , Antibodies, Antineutrophil Cytoplasmic , HumansSubject(s)
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/complications , Chagas Disease/complications , Myositis/immunology , Retroperitoneal Fibrosis/immunology , Arterioles/pathology , Chronic Disease , Humans , Male , Middle Aged , Myositis/pathology , Positron Emission Tomography Computed Tomography , Retroperitoneal Fibrosis/diagnostic imagingABSTRACT
Antecedentes. La sarcopenia se caracteriza por la pérdida de masa y fuerza muscular esquelética y representa un factor de riesgo de fragilidad, pérdida de independencia y discapacidad física. Este estudio pretende valorar la prevalencia de sarcopenia en una población de pacientes ingresados en una unidad de media-larga estancia. Pacientes y métodos. Estudio descriptivo, longitudinal y observacional que incluyó a 166 pacientes mayores de 18 años ingresados de forma consecutiva durante un año para tratamiento paliativo, convalecencia o rehabilitación. Se registraron datos administrativos y antropométricos. La detección de sarcopenia se realizó mediante la valoración de la fuerza muscular en cintura escapular y pélvica, fuerza prensil en manos, masa muscular y de la capacidad funcional física. Resultados. La prevalencia global de sarcopenia fue del 77,6%. La mayor parte de los pacientes con sarcopenia presentaban sarcopenia severa (91,2%), con los 3 parámetros valorados disminuidos: fuerza muscular (88,2%), masa muscular (85,5%) y rendimiento físico (94,70%). Conclusiones. La prevalencia de sarcopenia en los pacientes ingresados en nuestra unidad de media-larga estancia es muy elevada, superior a la descrita en población no institucionalizada, y con frecuencia tiene un grado importante de severidad (AU)
Background. Sarcopenia is characterized by the loss of skeletal muscle mass and strength and represents a risk factor for frailty, loss of independence and physical disabilities. This study aimed to assess the prevalence of sarcopenia in a population of patients admitted to a media and long-stay unit. Patients and methods. Descriptive, cross-sectional observational study that included 166 patients over 18 years who were admitted consecutively for a year to palliative care, convalescence or rehabilitation. Administrative and anthropometric data were recorded. Sarcopenia detection was performed by assessing the strength in the scapular and pelvic girdle muscles, grip strength in the hands, muscle mass and physical functional capacity. Results. The overall prevalence of sarcopenia was 77.6%. Most patients had severe sarcopenia (91.2%), with reduced levels of the 3 assessed parameters: muscle strength (88.2%), muscle mass (85.5%) and physical performance (94.70%). Conclusion. The prevalence of sarcopenia in patients admitted to our media and long-stay unit is higher than that reported in noninstitutionalized populations, and often has a significant degree of severity (AU)
Subject(s)
Humans , Male , Female , Adult , Middle Aged , Sarcopenia/epidemiology , Muscle Contraction , Muscle Contraction/physiology , Informed Consent/ethics , Informed Consent/legislation & jurisprudence , Psychomotor Performance/physiology , Length of Stay/trends , Muscle Strength/physiology , Longitudinal Studies/methods , Longitudinal Studies , Palliative Care/trendsABSTRACT
BACKGROUND: Sarcopenia is characterized by the loss of skeletal muscle mass and strength and represents a risk factor for frailty, loss of independence and physical disabilities. This study aimed to assess the prevalence of sarcopenia in a population of patients admitted to a media and long-stay unit. PATIENTS AND METHODS: Descriptive, cross-sectional observational study that included 166 patients over 18 years who were admitted consecutively for a year to palliative care, convalescence or rehabilitation. Administrative and anthropometric data were recorded. Sarcopenia detection was performed by assessing the strength in the scapular and pelvic girdle muscles, grip strength in the hands, muscle mass and physical functional capacity. RESULTS: The overall prevalence of sarcopenia was 77.6%. Most patients had severe sarcopenia (91.2%), with reduced levels of the 3 assessed parameters: muscle strength (88.2%), muscle mass (85.5%) and physical performance (94.70%). CONCLUSION: The prevalence of sarcopenia in patients admitted to our media and long-stay unit is higher than that reported in noninstitutionalized populations, and often has a significant degree of severity.
ABSTRACT
No disponible
